INTRODUCTION AND OBJECTIVES: Average age of prostate cancer (PCa) diagnosis is 66, with most men diagnosed between 65-74. Beyond National Cancer Comprehensive Network risk stratum, age is often used to determine the suitability of treatment options based on cancer control benefits. For aging men, health-related quality of life (HRQoL) concerns are crucial as oncologic survival outcomes can be difficult to predict. In this study, we examined the impact of age on HRQoL in men undergoing radical prostatectomy (RP).
METHODS: A retrospective cohort study was conducted on enrollees in the Center for Prostate Disease Research (CPDR) Multicenter National Database diagnosed with PCa (2007 PCa ( -2013 and receiving RP as primary treatment. Expanded Prostate Cancer Index Composite and RAND 36 Item Short Form Health Survey questionnaires were completed pre-treatment and at regular follow up intervals. Patients with baseline HRQoL data baseline and ! 1 year follow up were included. Men without baseline or follow up data and men who received other treatments were excluded. Patients were grouped based on age at RP: <60, 60-70, >70 yrs. Demographics, oncologic characteristics and HRQoL scores were obtained and compared across age groups. Multivariable generalized estimating equations were used to model change in HRQoL over time as a function of age group.
RESULTS: 500 men met the inclusion criteria: 214 (42.8%) were < 60, 234 (46.8%) were 60-70, 52 (10.4%) were >70; mean follow up for each group was 4.9, 5.0, and 5.2 yrs respectively. Men aged 60-70 and >70 had significantly lower baseline sexual function (p<0.0001), urinary bother (p[0.03) and sexual bother (p<0.0001) scores vs. men <60. No difference was found between groups in any other mental or physical HRQoL scores when adjusted for baseline HRQoL, risk category, race, comorbidities and time since treatment (Fig. 1) . Men >70 had a significantly lower hormonal bother score than younger men (p[0.04).
CONCLUSIONS: HRQoL counseling is critical for men undergoing RP. This study shows that men >70 may experience greater hormonal bother than younger men undergoing RP. Otherwise, when baseline function is accounted for, no difference in HRQoL exists in older vs. younger men in this population. RP should be considered for all patients based on guidelines rather than age-based HRQoL concerns. 
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PD45-07 ASSESSING THE QUALITY OF SURGICAL CARE FOR CLINICALLY LOCALIZED PROSTATE CANCER: RESULTS FROM THE CEASAR STUDY
Peter Reisz*, Nashville, TN; Zhiguo Zhao, Nashville, TN, TN; Li-Ching Huang, Tatsuki Koyama, Nashville, TN; Karen Hoffman, Houston, TX; Ralph Conwill, David Penson, Daniel Barocas, Nashville, TN INTRODUCTION AND OBJECTIVES: Previous studies have suggested that there is racial, geographic, and socioeconomic variation in outcomes for localized prostate cancer, which raises concern for disparities in quality of care. Using a prospective, population-based cohort, we sought to measure clinically relevant variation in structure, process, and outcome measures across racial groups, age groups, surgical approach, and surgeon volume.
METHODS: The Comparative Effectiveness Analysis of Surgery and Radiation (CEASAR) Study enrolled 1,523 men with clinically localized prostate cancer diagnosed between 2011 and 2012 who underwent radical prostatectomy, of whom 1,069 met final inclusion criteria. Quality of life was assessed longitudinally using the Expanded Prostate Index Composite (EPIC-26), and clinical data were collected by chart review. Six quality measures were assessed: pelvic lymphadenectomy when risk of lymph node involvement ! 2%, nerve-sparing among men with D'Amico low-risk disease and good baseline sexual function (EPIC sexual function domain score > 80), negative surgical margins, urinary and sexual function outcomes, treatment by a highvolume surgeon (>10 cases in cohort), and 30-day and one-year complications. Receipt of high quality care was compared across categories of race, age, surgeon volume, and surgical approach.
RESULTS: Table 1 shows the proportion meeting each dichotomous quality measure across exposure groups. There were no significant differences in quality between white and African-American patients, among age groups, or across strata of surgeon volume. However, the robotic surgery patients were less likely to undergo lymphadenectomy when indicated, and less likely to be treated by a high-volume surgeon. Patients undergoing open surgery had
